In Vitro Human Scleral Permeability of Fluorescein, Dexamethasone-Fluorescein, Methotrexate-Fluorescein and Rhodamine 6G and the Use of a Coated Coil as a New Drug Delivery System
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
PURPOSE: To determine the in vitro human scleral permeability of several dyes and drugdye combinations with varying molecular weights (MW) and lipid solubilities (fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein, and rhodamine). Coils coated with rhodamine were also evaluated for scleral permeability and sustained release. METHODS: Scleral sections excised from moist chamber stored human globes were mounted in a 2-compartment perfusion chamber. A small depot of drug/dye (100 microl of 10(-4) M fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein or rhodamine) or a coated coil in 100 microl of BSS was added to the episcleral surface while perfusing BSS to the choroidal side. The perfusate was collected and measured for fluorescence. Permeability was calculated as Ktrans from the flux measurements. RESULTS: Ktrans values (cm/sec, mean +/- SE) for the studied dyes and drug-dye combinations were 5.21 +/- 0.71 x 10(-6) for fluorescein, 1.64 +/- 0.17 x 10(-6) for dexamethasone-fluorescein, 3.36 +/- 0.62 x 10(-6) for methotrexate-fluorescein, 1.86 +/- 0.39 x 10(-6) for rhodamine and 2.18 +/- 0.23 x 10(-6) for the rhodamine from the coils. We found a significant difference between the permeability of the sclera to fluorescein and dexamethasone-fluorescein (P < 0.001), methotrexate-fluorescein (P < 0.05) and rhodamine (P < 0.001). Steady state flux was observed from the rhodamine coil. CONCLUSION: The rank order of scleral permeability to the studied dyes is as follows: fluorescein > methotrexate-fluorescein > rhodamine coil > rhodamine 6G > dexamethasone-fluorescein. Differences in scleral permeability are related to MW and lipid solubility. Prolonged transscleral diffusion of rhodamine delivered by solution and by coil are similar.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627 · cited 1×
“The permeability values we found in this study were comparable to those reported by Rudnick et al. (7) and slightly lower for compounds with similar molecular weight in other previous studies of human scleral permeability (10).”
(2000) · PubMed · Cited by 358
Ocular drug delivery conventional ocular formulations
Lang, J. C. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00012-v · Cited by 356
Human sclera: Thickness and surface area
Olsen, T. W., Aaberg, S. Y., Geroski, D. H., & Edelhauser, H. F. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80096-8 · Cited by 349 · cited 1×
“With an average surface area of 16.3 cm 2 and accounting for 95% of the total surface area of the globe (6), the sclera provides a large possible pathway to the posterior segment of the eye.”
InfluentialSelf-citationDrug delivery for posterior segment eye disease.
Geroski, D. H., & Edelhauser, H. F. (2000) · PubMed · Cited by 342
Self-citationCharacterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Hämäläinen, K. M., Kananen, K., Auriola, S. O. K., Kontturi, K., & Urtti, A. O. (1997) · PubMed · Cited by 266
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Self-citationTransscleral delivery of bioactive protein to the choroid and retina.
Ambati, J., Gragoudas, E. S., Miller, J. W., You, T., Miyamoto, K., Delori, F. C., & Adamis, A. P. (2000) · PubMed · Cited by 207
Mechanisms of absorption enhancement and tight junction regulation
Hochman, J., & Artursson, P. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90072-8 · Cited by 186 · cited 1×
“Furthermore, due to the hypocel-lularity of the human sclera, proteolytic enzymes and protein-binding sites that could interfere with drug diffusion are limited (20).”
Maurice, D. M., & Polgar, J. (1977) · Experimental Eye Research · doi:10.1016/0014-4835(77)90136-1 · Cited by 127
Research works printed but not linked: 8
- Olsen T.W., 1995, Invest. Ophthalmol. Vis. Sci., 36, 1893
- Geroski D.H., 2000, Invest. Ophthalmol. Vis. Sci., 41, 961
- Rudnick D.E., 1999, Invest. Ophthalmol. Vis. Sci., 40, 3054
- Ambati J., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1181
- Maurice D.M., 1984, New York, 19
- Foster C.S., 1994, New York, 1
- Hämäläinen K.M., 1997, Invest. Ophthalmol. Vis. Sci., 38, 627
- Ambati J., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1186
Cited by
Varela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., Fernández-Ferreiro, A., & Otero-Espinar, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 354
“It is composed of collagen fibers, proteoglycans, and glycoprot ins, creati g a n twork in an aqueous m dium [14,15].”
BackgroundNanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
“In agreement with the previous study, Cruysberg and colleagues demonstrated that the permeability of sodium fluorescein across human sclera in an in vitro transport/diffusion experimental design is higher than that of rhodamine 6G (Cruysberg et al., 2002).”
ResultPeriocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
“Figure 4 [53-57] summarises the permeability coefficients for several solutes across human sclera.”
BackgroundOvercoming ocular drug delivery barriers through the use of physical forces
Huang, D., Chen, Y.-S., & Rupenthal, I. D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.008 · Cited by 227
Recent Advances in Ocular Drug Delivery Systems
Kuno, N., & Fujii, S. (2011) · Polymers · doi:10.3390/polym3010193 · Cited by 202
“Hydrophobicity of drugs affects scleral permeability; increase of lipophilicity shows lower permeability; and hydrophilic drugs may diffuse through the aqueous medium of proteoglycans in the fiber matrix pores more easily than lipophilic drugs [26,27].”
Background
Metadata
- Authors
- Cruysberg, L. P. J., Nuijts, R. M. M. A., Geroski, D. H., Koole, L. H., Hendrikse, F., & Edelhauser, H. F.
- Affiliations
- Emory University (US)
- Maastricht University Medical Centre (NL)
- Department of Ophthalmology and Center of Biomaterials, University Hospital of Maastricht, The Netherlands
- Venue
- Journal of Ocular Pharmacology and Therapeutics
- Publisher
- SAGE Publications
- Published
- 2002-11
- Volume
- 18
- Issue
- 6
- Pages
- 559-569
- ISSN
- 1080-7683 (ISSN-L)
- 1557-7732
- OpenAlex
- W1997156360
- Cited by
- 77
- References
- 19
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Journal of Ocular Pharmacology and Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Research to Prevent Blindness
- National Eye Institute (P-30-EY06360, P30EY006360)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- scleral permeability, fluorescein, rhodamine 6G, sustained drug release, molecular weight, lipid solubility, ocular drug delivery, fluorescein clearance, choroidal blood flow
- MeSH terms
- Contrast Media, Dexamethasone, Drug Combinations, Fluorescent Dyes, Glucocorticoids, Humans, Methotrexate, Middle Aged, Permeability, Rhodamines, Sclera, Drug Delivery Systems, Fluorescein, Coated Materials, Biocompatible, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro Human Scleral Permeability of Fluorescein, Dexamethasone-Fluorescein, Methotrexate-Fluorescein and Rhodamine 6G and the Use of a Coated Coil as a New Drug Delivery System. https://app.cochat.ai/papers/10.1089/108076802321021108
- The paper
- Cruysberg, L. P. J., Nuijts, R. M. M. A., Geroski, D. H., Koole, L. H., Hendrikse, F., & Edelhauser, H. F. (2002). In Vitro Human Scleral Permeability of Fluorescein, Dexamethasone-Fluorescein, Methotrexate-Fluorescein and Rhodamine 6G and the Use of a Coated Coil as a New Drug Delivery System. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/108076802321021108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.